A new treatment based on combining two drugs—nivolumab and ipilimumab—may represent a milestone in how we treat skin cancer patients. More than half of these patients can now survive the condition (considered untreatable just a decade ago) thanks to a study led by the...
The Netherlands’ Erasmus University Medical Center and an international team of investigators has determined that SkinVision, the first CE-marked skin cancer application thoroughly tested in clinical studies, reports a sensitivity of 95.1% in detecting the most common...
Researchers from the Perelman School of Medicine at the University of Pennsylvania have identified a key regulator that impedes skin replacement—a blockage which can trigger the development of skin cancer. Published in Cell Reports, the team report that the skin’s...
Researchers from Denmark’s Aarhus University Hospital have shown that antibiotics administered to treat Staphylococcus aureus appeared to inhibit disease among patients with advanced cutaneous T-cell lymphoma. The prospective study results were published in Blood and...
Drexel University College of Medicine recently conducted a study on skin cancer in people of color—especially blacks. The common assumption is that black people do not contract skin cancer due to the amount of melanin in the skin. Investigators are learning that...
Jake Siegel of Fred Hutch News Service reports that a multidisciplinary research team involving University of Washington and Fred Hutchinson Cancer Research Center received a $12 million grant to study a deadly form of skin cancer known as Merkel cell carcinoma (MCC)....
